Eduardo Alegria
Overview
Explore the profile of Eduardo Alegria including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1570
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cordero A, Cid-Alvarez B, Alegria E, Fernandez-Cisnal A, Escribano D, Bautista J, et al.
Catheter Cardiovasc Interv
. 2021 Apr;
98(3):E342-E350.
PMID: 33829625
Background: Routine manual thrombectomy (MT) is not recommended in primary percutaneous coronary intervention (P-PCI) but it is performed in many procedures. The objective of our study was validating the DDTA...
2.
Ferrari R, Aguiar C, Alegria E, Bonadonna R, Cosentino F, Elisaf M, et al.
Eur Heart J Suppl
. 2017 May;
18(Suppl C):C2-C12.
PMID: 28533705
A panel of European experts on lipids and cardiovascular disease discussed clinical approaches to managing cardiovascular risk in clinical practice, including residual cardiovascular risk associated with lipid abnormalities, such as...
3.
Royo-Bordonada M, Armario P, Lobos Bejarano J, Pedro-Botet J, Villar Alvarez F, Elosua R, et al.
Semergen
. 2017 May;
43(4):295-311.
PMID: 28532894
The VI European Guidelines for Cardiovascular Prevention recommend combining population and high-risk strategies with lifestyle changes as a cornerstone of prevention, and propose the SCORE function to quantify cardiovascular risk....
4.
Royo-Bordonada M, Armario P, Lobos Bejarano J, Pedro-Botet J, Villar Alvarez F, Elosua R, et al.
Gac Sanit
. 2017 Mar;
31(3):255-268.
PMID: 28292529
The VI European Guidelines for Cardiovascular Prevention recommend combining population and high-risk strategies with lifestyle changes as a cornerstone of prevention, and propose the SCORE function to quantify cardiovascular risk....
5.
Royo-Bordonada M, Armario P, Lobos Bejarano J, Pedro-Botet J, Villar Alvarez F, Elosua R, et al.
Rev Esp Salud Publica
. 2016 Nov;
90:e1-e24.
PMID: 27880755
The VI European Guidelines for Cardiovascular Prevention recommend combining population and high-risk strategies with lifestyle changes as a cornerstone of prevention, and propose the SCORE function to quantify cardiovascular risk....
6.
Cordero A, Galve E, Bertomeu-Martinez V, Bueno H, Facila L, Alegria E, et al.
Rev Esp Cardiol (Engl Ed)
. 2015 Dec;
69(4):401-7.
PMID: 26631917
Introduction And Objectives: Chronic ischemic heart disease is the most prevalent of all cardiovascular diseases. Patients are at high risk of complications. In recent decades, changes may have occurred in...
7.
Aguiar C, Alegria E, Bonadonna R, Catapano A, Cosentino F, Elisaf M, et al.
Atheroscler Suppl
. 2015 Aug;
19:1-12.
PMID: 26315511
A meeting of European experts in cardiovascular (CV) disease and lipids was convened in Paris, France, on 10 November 2014 to discuss lipid profile, and in particular atherogenic dyslipidaemia (AD),...
8.
Galve E, Cordero A, Bertomeu-Martinez V, Facila L, Mazon P, Alegria E, et al.
Rev Esp Cardiol (Engl Ed)
. 2015 Jan;
68(2):136-43.
PMID: 25583549
As in other fields, understanding of vascular risk and rehabilitation is constantly improving. The present review of recent epidemiological update shows how far we are from achieving good risk factor...
9.
Cordero A, Facila L, Alegria E, Galve E
Rev Esp Cardiol (Engl Ed)
. 2014 Apr;
66(4):325-6.
PMID: 24775633
No abstract available.
10.
Galve E, Alegria E, Cordero A, Facila L, Fernandez de Bobadilla J, Lluis-Ganella C, et al.
Rev Esp Cardiol (Engl Ed)
. 2014 Apr;
67(3):203-10.
PMID: 24774395
Cardiovascular disease develops in a slow and subclinical manner over decades, only to manifest suddenly and unexpectedly. The role of prevention is crucial, both before and after clinical appearance, and...